Skip to main content

Guidance 18: Impurities in drug substances and drug products

(Updated from ARGPM Appendix 18: Impurities in active pharmaceutical ingredients and finished products)

Guidance on requirements relating to impurities in prescription medicines entered in the Australian Register of Therapeutic Goods (ARTG)

Last updated

Help us improve the Therapeutic Goods Administration site